Skip to main content

EverSource Wealth Advisors, LLC

SEC CIK
0001710537
Latest filing
Jul 24, 2026

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by EverSource Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings

Shares (Q2 2026)
35
Value
$647
% of portfolio
<0.1%
Quarters held
2
Since Q1 2026
Holdings of AVTX by EverSource Wealth Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202635$647<0.1%00.0%UnchangedHolders
Q1 202635$523<0.1%+35NewHolders